down arrow

Bajaj Healthcare

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE411U01027
  • NSEID: BAJAJHCARE
  • BSEID: 539872
INR
580.50
18.35 (3.26%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.23 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

571.40585.55

52 Week

265.00744.90
Valuation
Technical
Day's Volume

CASH

1.23 lacs (-60.44%) Volume

Shareholding (Dec 2024)

FII

1.01%

Held by 5 FIIs

DII

2.36%

Held by 2 DIIs

Promoter

59.19%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

High Management Efficiency with a high ROCE of 16.44%

 
2

Poor long term growth as Net Sales has grown by an annual rate of 1.53% and Operating profit at 10.97% over the last 5 years

 
3

Flat results in Dec 24

4

Stock is technically in a Mildly Bullish range

5

With ROCE of 9, it has a Expensive valuation with a 3.1 Enterprise value to Capital Employed

6

Majority shareholders : Promoters

 
7

Market Beating performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 1,833 Cr (Small Cap)

stock-summary
P/E

41.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.18%

stock-summary
Debt Equity

0.41

stock-summary
Return on Equity

9.83%

stock-summary
Price to Book

3.98

Revenue and Profits (1 Year):
Net Sales:
123 Cr
(Quarterly Results - Dec 2024)
Net Profit:
12 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.18%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
52.76%
0%
52.76%
1 Year
82.26%
0.31%
82.57%
2 Years
81.6%
0.62%
82.22%
3 Years
57.55%
1.19%
58.74%
4 Years
155.76%
1.24%
157.0%
5 Years
414.51%
3.31%
417.82%

Latest dividend: 1 per share ex-dividend date: Sep-23-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
1.53%
EBIT Growth (5y)
10.97%
EBIT to Interest (avg)
6.94
Debt to EBITDA (avg)
2.52
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.15
Tax Ratio
22.99%
Dividend Payout Ratio
-3.29%
Pledged Shares
0
Institutional Holding
3.37%
ROCE (avg)
16.35%
ROE (avg)
17.87%
Valuation key factors
Factor
Value
P/E Ratio
41
Industry P/E
33
Price to Book Value
3.98
EV to EBIT
33.18
EV to EBITDA
22.58
EV to Capital Employed
3.11
EV to Sales
3.75
PEG Ratio
0.45
Dividend Yield
0.18%
ROCE (Latest)
8.97%
ROE (Latest)
9.83%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Bullish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (1.64%)

FIIs

Held by 5 FIIs (1.01%)

Promoter with highest holding

Sajankumar Rameshwarlal Bajaj (30.75%)

Highest Public shareholder

Weststone Management Consultancy Pvt Ltd (2.06%)

Individual Investors Holdings

26.94%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 13.10% vs -18.10% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 632.73% vs -119.91% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "122.79",
          "val2": "108.57",
          "chgp": "13.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "21.64",
          "val2": "19.53",
          "chgp": "10.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.51",
          "val2": "6.65",
          "chgp": "-17.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.24",
          "val2": "-7.72",
          "chgp": "58.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "11.72",
          "val2": "-2.20",
          "chgp": "632.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.62%",
          "val2": "17.99%",
          "chgp": "-0.37%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 14.89% vs -35.69% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 132.13% vs -282.06% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "265.34",
          "val2": "230.95",
          "chgp": "14.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "49.04",
          "val2": "40.70",
          "chgp": "20.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "16.32",
          "val2": "17.01",
          "chgp": "-4.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.23",
          "val2": "-63.82",
          "chgp": "100.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "16.60",
          "val2": "-51.67",
          "chgp": "132.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.48%",
          "val2": "17.62%",
          "chgp": "0.86%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 14.32% vs -30.95% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 152.57% vs -236.62% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "388.13",
          "val2": "339.52",
          "chgp": "14.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "70.68",
          "val2": "60.23",
          "chgp": "17.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "21.83",
          "val2": "23.66",
          "chgp": "-7.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.01",
          "val2": "-71.54",
          "chgp": "95.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "28.32",
          "val2": "-53.87",
          "chgp": "152.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.21%",
          "val2": "17.74%",
          "chgp": "0.47%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -26.69% vs -5.01% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -294.77% vs -39.74% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "473.42",
          "val2": "645.80",
          "chgp": "-26.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "76.27",
          "val2": "111.37",
          "chgp": "-31.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "29.68",
          "val2": "17.56",
          "chgp": "69.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-113.80",
          "val2": "-20.51",
          "chgp": "-454.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-83.79",
          "val2": "43.02",
          "chgp": "-294.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.11%",
          "val2": "17.25%",
          "chgp": "-1.14%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
122.79
108.57
13.10%
Operating Profit (PBDIT) excl Other Income
21.64
19.53
10.80%
Interest
5.51
6.65
-17.14%
Exceptional Items
-3.24
-7.72
58.03%
Standalone Net Profit
11.72
-2.20
632.73%
Operating Profit Margin (Excl OI)
17.62%
17.99%
-0.37%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 13.10% vs -18.10% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Dec 2024 is 632.73% vs -119.91% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
265.34
230.95
14.89%
Operating Profit (PBDIT) excl Other Income
49.04
40.70
20.49%
Interest
16.32
17.01
-4.06%
Exceptional Items
0.23
-63.82
100.36%
Standalone Net Profit
16.60
-51.67
132.13%
Operating Profit Margin (Excl OI)
18.48%
17.62%
0.86%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 14.89% vs -35.69% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 132.13% vs -282.06% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
388.13
339.52
14.32%
Operating Profit (PBDIT) excl Other Income
70.68
60.23
17.35%
Interest
21.83
23.66
-7.73%
Exceptional Items
-3.01
-71.54
95.79%
Standalone Net Profit
28.32
-53.87
152.57%
Operating Profit Margin (Excl OI)
18.21%
17.74%
0.47%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 14.32% vs -30.95% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 152.57% vs -236.62% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
473.42
645.80
-26.69%
Operating Profit (PBDIT) excl Other Income
76.27
111.37
-31.52%
Interest
29.68
17.56
69.02%
Exceptional Items
-113.80
-20.51
-454.85%
Standalone Net Profit
-83.79
43.02
-294.77%
Operating Profit Margin (Excl OI)
16.11%
17.25%
-1.14%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -26.69% vs -5.01% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is -294.77% vs -39.74% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Bajaj Healthcare Ltd stock-summary
stock-summary
Bajaj Healthcare Ltd
Small Cap
Pharmaceuticals & Drugs
Bajaj Healthcare Ltd. is a bulk drug manufacturer established in 1993, serving various Pharmaceuticals, Nutraceuticals and Food industries globally with a spirit of scrupulousness. The Company commenced its operations in 1993 with a single unit at Tarapur. It became a public company in 2005 and listed its shares in the Indian stock exchanges in 2016. With Headquartered in Thane, Company has established 3 API plants in Gujarat and Maharashtra.
Company Coordinates stock-summary
Company Details
602-606 Bhoomi Velocity Infote, Road No 23 Wagle Indl Estate Thane Maharashtra : 400604
stock-summary
Tel: 91-22-66177400/401
stock-summary
http://www.bajajhealth.com
stock-summary
investors@bajajhealth.com
Registrar Details
Sharex Dynamic (India) Pvt Ltd , Unit -1, Luthra Ind. Premises , Safed Pool, Andheri-Kurla Road, Andheri (E), Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."